Blackwell Burke P.A. partner Peter J. Goss was quoted recently in a Law360 article discussing the possible federal court consolidation of Biomet Inc.’s metal hip implant personal injury cases. The device manufacturer will argue today that its cases are too varied to be consolidated into multi-district litigation. The federal panel considering the consolidation, however, has already consolidated litigation for other similar cases involving metal implants. In light of this precedent, Goss commented that the federal panel will likely follow suit in Biomet’s case, unless Biomet shows that it is unlikely similar cases will be filed. The article, “Past Metal-Hip Fights May Haunt Biomet’s Bid to Avoid MDL,” is available here.
Mr. Goss focuses his national practice on pharmaceutical and medical device product liability litigation and toxic torts. He has represented major pharmaceutical, medical technology, and chemical firms in hundreds of cases. Mr. Goss, who has won several published Daubert decisions, often serves as “science counsel” in life sciences litigation. He collaborates with leading experts to present complex medical and scientific evidence, both in dispositive motions and at trial. He is a frequent commentator on scientific evidence and legal developments of interest to FDA-regulated industries.
Blackwell Burke P.A., a litigation and trial boutique in Minneapolis, Minnesota, serves as national trial and litigation counsel for numerous Fortune 500 companies. The firm has extensive experience in class action defense, commercial litigation, food industry defense, labor and employment, and products liability. The firm has represented corporate clients in practically every jurisdiction in the country, as well as several foreign countries.